Immune Landscapea | References | |
---|---|---|
WNT/βCatenin | Silent (0.03) | [38, 39] |
MAPK Hypothesis | Silent (0.001) | [10] |
Immunogenic Cell Death | Active (< 0.001) | [19], [20, 21] |
Regulatory T cells | Active (< 0.001) | [24, 25] |
IL23-Th17 Axis | Active (< 0.001) | [26, 41–44] |
Myeloid Suppressor Cells | Active (< 0.001) | [50] |
PI3K-γ Signature | Active (< 0.01) | [52–55, 63] |
IDO/NOS Signature | Active (< 0.01) | [51, 81, 82] |
SGK1 Signature | Ubiquitous | [56, 57] |
Shc1 signature | Ubiquitous | [62] |
Barrier Molecules | Ubiquitous | [27, 28] |
Mesenchymal Transition | Ubiquitous | [29, 30, 83] |
Cancer-Associated Fibroblasts | Ubiquitous | [31–35, 84] |
TAM receptor tyrosine kinases | Ubiquitous | [47, 58–60, 85] |
Hypoxia/Adenosine suppression | Ubiquitous | [48, 49] |
TREX1clearence of Cytosolic DNA | NA | [86, 87] |
Checkpoint Cluster | Active (< 0.001) | [22, 23] |
oncogene addicted tumors | Silent | [11, 68] |
Epigenetic Regulation | Ubiquitous | [12, 88–90] |
aDistinct models have been assigned to either the Silent or the Active Landscape according to the results of the survey shown in Fig. 1 . Ubiquitous refers to models that are not significantly associated with either immune landscape